A 3-year-old with acute otitis media treated with amoxicillin, now has a type B tympanogram, fever (102.5°F), and a bulging tympanic membrane. What will the primary care pediatric nurse practitioner order?

A 3-year-old with acute otitis media treated with amoxicillin, now has a type B tympanogram, fever (102.5°F), and a bulging tympanic membrane. What will the primary care pediatric nurse practitioner order?

• A. Amoxicillin-clavulanate twice daily
• B. A referral for tympanocentesis
• C. Amoxicillin twice daily
• D. Intramuscular ceftriaxone

Answer: (A)

When acute otitis media does not respond to the initial antibiotic, broaden the antibiotic choice to cover beta-lactamase–producing organisms. The child still has fever and a bulging, inflamed tympanic membrane with a type B tympanogram, which indicates persistent middle-ear infection. Amoxicillin-clavulanate adds clavulanate to inhibit beta-lactamases produced by common AOM pathogens like Moraxella catarrhalis and some strains of Haemophilus influenzae, making it more effective than amoxicillin alone in this setting. This approach targets the likely resistant organisms and aligns with guidelines for treatment failure after initial therapy. Tympanocentesis isn’t routinely indicated in outpatient AOM and is reserved for specific diagnostic or treatment failure scenarios with complications. Intramuscular ceftriaxone is typically considered when oral therapy isn’t feasible or after failed oral therapy in certain cases, but starting with oral amoxicillin-clavulanate is preferred here due to most cases of persistent AOM being manageable with broadened oral antibiotics. Continuing plain amoxicillin would miss coverage for beta-lactamase–producing organisms, increasing the chance of ongoing infection.

When acute otitis media does not respond to the initial antibiotic, broaden the antibiotic choice to cover beta-lactamase–producing organisms. The child still has fever and a bulging, inflamed tympanic membrane with a type B tympanogram, which indicates persistent middle-ear infection. Amoxicillin-clavulanate adds clavulanate to inhibit beta-lactamases produced by common AOM pathogens like Moraxella catarrhalis and some strains of Haemophilus influenzae, making it more effective than amoxicillin alone in this setting. This approach targets the likely resistant organisms and aligns with guidelines for treatment failure after initial therapy.

Tympanocentesis isn’t routinely indicated in outpatient AOM and is reserved for specific diagnostic or treatment failure scenarios with complications. Intramuscular ceftriaxone is typically considered when oral therapy isn’t feasible or after failed oral therapy in certain cases, but starting with oral amoxicillin-clavulanate is preferred here due to most cases of persistent AOM being manageable with broadened oral antibiotics. Continuing plain amoxicillin would miss coverage for beta-lactamase–producing organisms, increasing the chance of ongoing infection.